Long-term survival in primary CNS lymphoma

Journal of Clinical Oncology

Volumn 16, Issue 3, 1998, Pages 859-863

  Abrey, Lauren E ^a   DeAngelis, Lisa M ^a   Yahalom, Joachim ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; FOLINIC ACID; METHOTREXATE; PREDNISONE; VINCRISTINE;

ADULT; AGED; AGING; ARTICLE; BRAIN LYMPHOMA; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL ARTICLE; FEMALE; HUMAN; MALE; MULTIMODALITY CANCER THERAPY; NEUROTOXICITY; ONSET AGE; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE;

EID: 0031887689     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1998.16.3.859     Document Type: Article

References (15)

1. Glass J, Gruber ML, Cher L, et al: Preirradiation methotrexate chemotherapy of primary central nervous system lymphoma: Long-term outcome. J Neurosurg 81:188-195, 1994
2. DeAngelis LM, Yahalom J, Thaler HT, et al: Combined modality therapy for primary CNS lymphoma. J Clin Oncol 10:635-643, 1992
3. Dahlborg SA, Henner WD, Crossen JR, et al: Non-AIDS primary CNS lymphoma: First example of a durable response in a primary brain tumor using enhanced chemotherapy without cognitive loss and without radiotherapy. Cancer J Sci Am 2:166-174, 1996
4. Gabbai AA, Hochberg FH, Linsgood RM, et al: High-dose methotrexate for non-AIDS primary central nervous system lymphoma. J Neurosurg 70:190-194, 1989
5. Lachance DH, Brizel DM, Gockerman JP, et al: Cyclophosphamide, doxorubicin, vincristine, and prednisone for primary central nervous system lymphoma: Short duration response and multifocal intracerebral recurrence preceding radiotherapy. Neurology 44:1721-1727, 1994
6. Schultz C, Scott C, Sherman W, et al: Preirradiation chemotherapy with cyclophosphamide, doxorubicin, vincristine, and dexamethasone for primary CNS lymphomas: Initial report of Radiation Therapy Oncology Group Protocol 88-06. J Clin Oncol 14:556-564, 1996
7. Nelson DF, Martz KL, Bonner H, et al: Non-Hodgkin's lymphoma of the brain: Can high-dose, large-volume radiation therapy improve survival? Report on a prospective trial by the Radiation Therapy Oncology Group (RTOG): RTOG:8315. Int J Radiat Oncol Biol Phys 23:9-17, 1992
8. Fine HA, Mayer RJ: Primary central nervous system lymphoma. Ann Intern Med 119:1093-1104, 1993
9. Bleyer WA: Neurologic sequelae of methotrexate and ionizing radiation: A new classification. Cancer Treat Rep 65:89-98, 1981 (suppl 1)
10. DeAngelis LM, Delattre JY, Posner JB: Radiation-induced dementia in patients cured of brain metastases. Neurology 39:789-796, 1989
11. Duffey P, Chari G, Cartlidge NEF, et al: Progressive deterioration of intellect and motor function occurring several decades after cranial irradiation. Arch Neurol 53:814-818, 1996
12. Crossen JR, Garwood D, Glatstein E, et al: Neurobehavioral sequelae of cranial irradiation in adults: A review of radiation-induced encephalopathy. J Clin Oncol 12:627-642, 1994
13. McGuirt WF, Feehs RS, Strickland JL, et al: Irradiation induced atherosclerosis: A factor in therapeutic planning. Ann Oto Rhinol Laryngol 101:222-228, 1992
14. Thiessen B, DeAngelis LM: Hydrocephalus following cranial radiotherapy: Results of ventriculoperitoneal shunting. Neurology 48: A29, 1997
15. Freilich RJ, Delattre JY, Monjour A, et al: Chemotherapy without radiation therapy as initial treatment for primary CNS lymphoma in older patients. Neurology 46:435-439, 1996